At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Nov 10, 2026 at 16:59 ET
Two BeOne Medicines insiders sold a combined $805K in open-market sales within a week of the company's strong Q3 earnings beat and raised guidance. The sales are modest relative to market cap and include a 10b5-1 plan sale, reducing the signal.
- Principal Accounting Officer sold 1.5K shares at $405.55 for $622K (no 10b5-1 plan)
- SVP General Counsel sold 455 shares at $402 for $183K (under 10b5-1 plan)
- Total open-market sales: $805K
- Sales occurred 0-1 day after Q3 earnings beat (revenue +34% YoY, EPS +201% YoY, guidance raised)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access